When I talk about responsible innovation (RI) with people who are unfamiliar with the concept, among the most frequent reactions is, “Who could be against that?” – meaning, I suspect, that both res...
No takes yet. Share an insight, caveat, or question.
David H. Guston (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: